Detailed answers about TSE ENGINEERING PHARMA CONSULTANT LIMITED, including incorporation, status, business activity, and accounts information.
When was TSE ENGINEERING PHARMA CONSULTANT LIMITED founded?
TSE ENGINEERING PHARMA CONSULTANT LIMITED was officially incorporated on 5 February 2026 and is registered under company number 17014857. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is TSE ENGINEERING PHARMA CONSULTANT LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of TSE ENGINEERING PHARMA CONSULTANT LIMITED?
TSE ENGINEERING PHARMA CONSULTANT LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does TSE ENGINEERING PHARMA CONSULTANT LIMITED do?
TSE ENGINEERING PHARMA CONSULTANT LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is TSE ENGINEERING PHARMA CONSULTANT LIMITED's registered address?
The registered office address of TSE ENGINEERING PHARMA CONSULTANT LIMITED is 4 GLANVILLE DRIVE, HORNCHURCH, ESSEX, ENGLAND, RM11 3SZ. This is the official address filed with Companies House for legal and statutory correspondence.
Is TSE ENGINEERING PHARMA CONSULTANT LIMITED financially stable?
Financial accounts for TSE ENGINEERING PHARMA CONSULTANT LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.